about
Can additional information be obtained from claims data to support surgical site infection diagnosis codes?Incidence of Surgical Site Infection Following Mastectomy With and Without Immediate Reconstruction Using Private Insurer Claims Data.Bayesian estimation of the accuracy of ICD-9-CM- and CPT-4-based algorithms to identify cholecystectomy procedures in administrative data without a reference standard.Sepsis surveillance from administrative data in the absence of a perfect verification.Comparison of costs of surgical site infection and endometritis after cesarean delivery using claims and medical record data.Risk Factors for Surgical Site Infection After Cholecystectomy.The preventability of ventilator-associated events. The CDC Prevention Epicenters Wake Up and Breathe Collaborative.Delayed-onset cytomegalovirus disease coded during hospital readmission after kidney transplantation.Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: does methicillin resistance matter?Contamination of environmental surfaces with Staphylococcus aureus in households with children infected with methicillin-resistant S aureus.Baseline hypovitaminosis D is not associated with poor clinical outcomes in osteoarticular infectionsIncidence, risk factors, and outcomes of delayed-onset cytomegalovirus disease in a large, retrospective cohort of heart transplant recipientsTemporal trends in the systemic inflammatory response syndrome, sepsis, and medical coding of sepsis.Delayed-onset cytomegalovirus disease coded during hospital readmission in a multicenter, retrospective cohort of liver transplant recipients.Medications and Patient Characteristics Associated With Falling in the Hospital.Procedure-specific surgical site infection incidence varies widely within certain National Healthcare Safety Network surgery groupsModification of claims-based measures improves identification of comorbidities in non-elderly women undergoing mastectomy for breast cancer: a retrospective cohort study.Stratification of surgical site infection by operative factors and comparison of infection rates after hernia repair.Quantifying the improvement in sepsis diagnosis, documentation, and coding: the marginal causal effect of year of hospitalization on sepsis diagnosis.Increased Risk of Surgical Site Infection Among Breast-Conserving Surgery Re-excisions.Emergency Department Central Line-associated Bloodstream Infections (CLABSI) Incidence in the Era of Prevention PracticesIdentification of a pseudo-outbreak of Clostridium difficile infection (CDI) and the effect of repeated testing, sensitivity, and specificity on perceived prevalence of CDI.Developing a risk stratification model for surgical site infection after abdominal hysterectomy.Pharmacoepidemiology of cytomegalovirus prophylaxis in a large retrospective cohort of kidney transplant recipients with Medicare Part D coverage.Effect of Noninfectious Wound Complications after Mastectomy on Subsequent Surgical Procedures and Early Implant Loss.Potentially pathogenic bacteria in shower water and air of a stem cell transplant unitRates and timing of central venous cannulation among patients with sepsis and respiratory arrest admitted by the emergency department*Use of Medicare claims to rank hospitals by surgical site infection risk following coronary artery bypass graft surgery.Enhanced surgical site infection surveillance following hysterectomy, vascular, and colorectal surgery.Comparison of Wound Complications After Immediate, Delayed, and Secondary Breast Reconstruction Procedures.Use of Quantile Regression to Determine the Impact on Total Health Care Costs of Surgical Site Infections Following Common Ambulatory Procedures.Validation of ICD-9-CM Diagnosis Codes for Surgical Site Infection and Noninfectious Wound Complications After Mastectomy.A Central Line Care Maintenance Bundle for the Prevention of Central Line-Associated Bloodstream Infection in Non-Intensive Care Unit SettingsThe Effect of Clinical Chorioamnionitis on Cesarean Delivery in the United States.Prevalence and Predictors of Postdischarge Antibiotic Use Following Mastectomy.Longitudinal Study of the Effects of Bacteremia and Sepsis on 5-year Risk of Cardiovascular Events.Between community and hospital: healthcare-associated gram-negative bacteremia among hospitalized patients.An evaluation of dental antibiotic prescribing practices in the United States.Outpatient Antibiotic Prescription Trends in the United States: A National Cohort Study.An Innovative Program to Support Gender Equity and Success in Academic Medicine: Early Experiences From the Doris Duke Charitable Foundation's Fund to Retain Clinical Scientists.
P50
Q30851215-9F2066C4-85B4-47BC-B87D-96979267795AQ30964042-E9BB42A0-1B79-48FA-8014-46785F7657B8Q30992218-145A5921-B42D-4233-8511-08F682695C07Q31127051-0E3A7B94-7582-427B-A94E-C14BFAC6D213Q33618275-75C40D71-0EF0-4A06-8A87-E0AE8BB1BA85Q33641890-A16FC42F-92B7-4BFB-8E61-7A822F83F62EQ33735582-B637ACE2-6C05-443F-8DDA-FD812B2CB460Q33911369-EC3F84CF-8B79-49A1-8648-FA3C25BA89BCQ34133374-AE33AEAC-1153-48D8-B8A9-9449626B85C7Q34437424-69D3069D-AEF8-49A7-A204-418B64611B0BQ34519245-CF21141D-4F13-4767-AC85-2D6974558653Q34729119-8FC5C8C0-C0B3-4FCE-A3EE-0946D9877938Q35849326-F016C1A9-B5D8-4841-AA95-7D1562FDF777Q35985337-34CB3D00-014E-4F50-9E5E-EB715802357CQ36069125-561C3059-1CDF-49DE-B50B-97FCD7A1E586Q36069489-C6CB7338-E61E-4C74-BB0A-14BD246D5EA3Q36104585-F87F72CA-6DB9-4FF5-8816-32C88C19355FQ36381327-85254E31-EFEF-4201-995B-F5AB25437278Q36395980-B46DC37A-133B-49CB-A328-6EF37F9EB351Q36410318-F01DC533-81B3-4B6B-843A-65EE2C34E8EDQ36435766-89F1D77E-9842-4A4A-8A98-2279C285545DQ36687662-DEFAF3D5-3CC8-403A-8FFA-320FE6FE0226Q36745806-D23C0993-B214-47ED-B11E-7B6E9849FEA6Q36759073-C2BD6D21-04E5-487D-92E8-865C5D130A6BQ36840048-FE82C5CF-BDBC-4E60-81EE-B97634EE0620Q37301690-C8BD3461-944A-42EE-91CF-46C4A8424B1AQ37620899-6C7140E5-D13C-41EB-8786-58ECA24F6636Q37902453-D032C68B-D42F-4DBA-9869-F4AE45D23951Q38023620-9AE6D206-496E-4359-B818-91D19371B84BQ38671820-1E58FA96-1C3C-4F93-BBCF-F768337F8631Q39036245-BCEEA34A-5BE1-485C-A3DD-997EBC3E3641Q39100908-55A0E183-5629-49DB-800F-0763EBB3016DQ39901474-D936F7D5-6114-4647-A43F-0D0FF62F6E93Q40027943-FE8C9B37-1431-4121-B61D-64A573125510Q40150449-CECBEC25-D4C1-4D53-B3C2-28FCFDADFED8Q40668939-347B16C4-98D3-4105-B018-809F0ED656B2Q42635619-CDE66542-4620-4749-B034-49164A5617A4Q47935192-399DE4EA-520D-478B-B48E-AC491B801B24Q51150895-D75388F3-6C5C-4796-AAEF-8614C2F2AC0AQ52648503-C79C1359-B0A3-4848-97A6-B070B7098D02
P50
description
investigador
@es
researcher
@en
name
Victoria J Fraser
@en
type
label
Victoria J Fraser
@en
prefLabel
Victoria J Fraser
@en
P31
P496
0000-0001-6251-0733